Related Experiment Video
Updated: Jan 27, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
Neuroendocrine cells of prostate cancer: biologic functions and molecular mechanisms
Yu-Hua Huang1, Ya-Qun Zhang2, Jiao-Ti Huang3
1Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Abstract:
Prostate cancer (PCa) is a major health risk for older men worldwide. Existing systemic therapies mostly target androgen receptor (AR). Although treatments are initially effective, the disease always recurs. A potential mechanism for the treatment failure is that PCa contains, in addition to the AR-positive luminal type tumor cells, a small component of neuroendocrine (NE) cells. The function of NE cells in PCa remains poorly understood, and one important characteristic of these cells is their lack of expression of AR and resistance to hormonal therapy. In addition, many patients develop the more aggressive small-cell neuroendocrine carcinoma (SCNC) after hormonal therapy. Although this clinical phenomenon of disease transformation from adenocarcinoma to SCNC is well established, the cell of origin for SCNC remains unclear. Recently, loss of function of Rb and TP53 and amplification and overexpression of MYCN and Aurora A kinase have been identified as important biomarkers and potential disease drivers. In this article, we systematically review the histology of normal prostate and prostate cancer including the main histologic types: adenocarcinoma and SCNC. We also review the findings from many studies using cellular and animal models as well as human specimens that attempt to understand the molecular mechanisms of treatment failure, disease progression, and tumor transformation from adenocarcinoma to SCNC.
Insights
Prostate cancer (PCa) treatment failure may involve neuroendocrine (NE) cells, which lack androgen receptors (AR) and can drive aggressive small-cell neuroendocrine carcinoma (SCNC) after therapy.
Area of Science:
- Oncology
- Urology
- Cell Biology
Background:
- Prostate cancer (PCa) is a significant health concern for aging men globally.
- Current systemic therapies primarily target the androgen receptor (AR), but disease recurrence is common.
- A subset of neuroendocrine (NE) cells within PCa, lacking AR expression, may contribute to treatment resistance and progression.
Purpose of the Study:
- To review the histology of normal prostate and PCa, including adenocarcinoma and small-cell neuroendocrine carcinoma (SCNC).
- To explore the molecular mechanisms underlying treatment failure, disease progression, and transformation from adenocarcinoma to SCNC.
- To understand the role of NE cells in PCa development and therapeutic resistance.
Main Methods:
- Systematic review of histology in normal prostate and PCa.
- Analysis of findings from cellular and animal models of PCa.
- Review of human specimen studies investigating PCa progression and transformation.
Main Results:
- PCa histology includes AR-positive luminal cells and AR-negative NE cells.
- NE cells are resistant to hormonal therapy and implicated in SCNC development.
- Biomarkers like Rb, TP53, MYCN, and Aurora A kinase are associated with aggressive PCa and SCNC.
Conclusions:
- Neuroendocrine cells play a critical role in prostate cancer treatment failure and transformation to aggressive SCNC.
- Understanding NE cell biology is crucial for developing effective therapies for advanced prostate cancer.
- Further research into biomarkers and molecular drivers is needed to combat PCa progression.
Related Concept Videos
Mechanical Protein Functions
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mechanical Protein Function
Mechanisms of Retrovirus-induced Cancers
What is Conservation Biology?
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

